{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:56:28Z","timestamp":1778903788391,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences and Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104013"],"award-info":[{"award-number":["82104013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108640","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T19:02:58Z","timestamp":1748458978000},"page":"108640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC"],"prefix":"10.1016","volume":"163","author":[{"given":"Tianyun","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xican","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qionglu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108640_bb0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/cid\/ciab452","article-title":"Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: does it work, which combination, and for which patients","volume":"73","author":"Rose","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108640_bb0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2025.108640_bb0015","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis, Cochrane Database","volume":"12","author":"Lo","year":"2022","journal-title":"Syst. Rev."},{"key":"10.1016\/j.bioorg.2025.108640_bb0020","article-title":"MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework","volume":"13","author":"Shoaib","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108640_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00159-21","article-title":"An interplay of multiple positive and negative factors governs methicillin resistance in Staphylococcus aureus","volume":"86","author":"Bilyk","year":"2022","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bioorg.2025.108640_bb0030","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2174\/0929867320666131119122520","article-title":"MRSA infections: from classical treatment to suicide drugs","volume":"21","author":"Drebes","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0035","doi-asserted-by":"crossref","first-page":"e00018","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology","volume":"31","author":"Lakhundi","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2025.108640_bb0040","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JCM.00775-12","article-title":"Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. Aureus, high vancomycin MIC, and outcome in serious S. Aureus infections","volume":"50","author":"Holmes","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108640_bb0045","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2025.108640_bb0050","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.2174\/0109298673249381231130111352","article-title":"Treatment of MRSA infection: where are we","volume":"31","author":"Nazli","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micres.2018.05.002","article-title":"Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development","volume":"212\u2013213","author":"Zhang","year":"2018","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bioorg.2025.108640_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.micpath.2018.07.025","article-title":"Role of BP*C@AgNPs in bap-dependent multicellular behavior of clinically important methicillin-resistant Staphylococcus aureus (MRSA) biofilm adherence: a key virulence study","volume":"123","author":"Zhang","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2025.108640_bb0065","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.bmc.2019.06.017","article-title":"Brown N, Discovery and development of DNA polymerase IIIC inhibitors to treat gram-positive infections","volume":"27","author":"Xu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01621-23","article-title":"Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile","volume":"68","author":"Bass\u00e8res","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.108640_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acsmedchemlett.8b00094","article-title":"Discovery and development of 8-substituted cycloberberine derivatives as novel antibacterial agents against MRSA","volume":"9","author":"Fan","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108640_bb0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejmech.2018.08.050","article-title":"Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents","volume":"157","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0085","first-page":"887","article-title":"Design, synthesis and anti-MRSA activities of cycloberberine derivatives with a novel chemical scaffold","volume":"53","author":"Fan","year":"2018","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.bioorg.2025.108640_bb0090","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/molecules24050984","article-title":"Evolution and antibacterial evaluation of 8-hydroxy-cycloberberine derivatives as a novel family of antibacterial agents against MRSA","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108640_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2019.02.058","article-title":"Synthesis and biological evaluation of 7-substituted cycloberberine derivatives as potent antibacterial agents against MRSA","volume":"168","author":"Yang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0100","first-page":"1627","article-title":"Anti-MRSA activities of cycloberberine derivatives with a novel chemical scaffold","volume":"54","author":"Fan","year":"2019","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.bioorg.2025.108640_bb0105","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1016\/j.bmcl.2010.09.045","article-title":"Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives","volume":"20","author":"Park","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108640_bb0110","series-title":"Clinical and laboratory standards institute (CLSI). Performance standards for antimicrobial susceptibility testing","first-page":"1","author":"Pa","year":"2014"},{"key":"10.1016\/j.bioorg.2025.108640_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep13637","article-title":"Selective in vivo and in vitro activities of 3,3\u2032-4-nitrobenzylidene-bis-4-hydroxycoumarin against methicillin-resistant Staphylococcus aureus by inhibition of DNA polymerase III","volume":"5","author":"Hou","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108640_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/14756360601114270","article-title":"Inhibition of a thermophilic deoxyribonucleic acid polymerase by fullerene derivatives","volume":"22","author":"Meng","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2013.07.026","article-title":"Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents","volume":"68","author":"Li","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115778","article-title":"Synthesis of peptidomimetics as antibiotic adjuvants for combination with aztreonam to combat MDR Pseudomonas aeruginosa","volume":"260","author":"Ma","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0135","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1021\/acs.jmedchem.1c02034","article-title":"Mechanistic studies and in vivo efficacy of an oxadiazole-containing antibiotic","volume":"65","author":"Naclerio","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114886","article-title":"Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)","volume":"245","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108640_bb0145","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.apsb.2023.03.002","article-title":"Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR gram-negative bacteria producing ESBLs","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:49:43Z","timestamp":1776919783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"alternative-id":["S0045206825005206"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108640","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108640"}}